|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0000768,
umls-concept:C0006142,
umls-concept:C0032246,
umls-concept:C0032790,
umls-concept:C0086418,
umls-concept:C0178719,
umls-concept:C0205210,
umls-concept:C0205225,
umls-concept:C0242793,
umls-concept:C0242957,
umls-concept:C0449774,
umls-concept:C0681842
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2004-5-7
|
|
pubmed:abstractText |
In an earlier study, the presence of aneuploidy, Her-2/neu overexpression, and ras overexpression in the same cells (triple-positive cells) was of prognostic significance (P < 0.015) in 91 patients with localized breast cancer (median follow up, 32 months). Here, we present results involving a larger group of patients with longer follow-up.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3042-52
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:15131041-Adult,
pubmed-meshheading:15131041-Aged,
pubmed-meshheading:15131041-Aged, 80 and over,
pubmed-meshheading:15131041-Breast Neoplasms,
pubmed-meshheading:15131041-DNA,
pubmed-meshheading:15131041-Disease-Free Survival,
pubmed-meshheading:15131041-Female,
pubmed-meshheading:15131041-Flow Cytometry,
pubmed-meshheading:15131041-Fluorescent Antibody Technique,
pubmed-meshheading:15131041-Humans,
pubmed-meshheading:15131041-Intracellular Space,
pubmed-meshheading:15131041-Lymph Nodes,
pubmed-meshheading:15131041-Mastectomy,
pubmed-meshheading:15131041-Middle Aged,
pubmed-meshheading:15131041-Prognosis,
pubmed-meshheading:15131041-Prospective Studies,
pubmed-meshheading:15131041-Receptor, erbB-2,
pubmed-meshheading:15131041-ras Proteins
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Intracellular patterns of Her-2/neu, ras, and ploidy abnormalities in primary human breast cancers predict postoperative clinical disease-free survival.
|
|
pubmed:affiliation |
Department of Human Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15212, USA. shakney@wpahs.org
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.
|
